🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Sulfur burps protocol — the definitive management thread

Sulfur burps protocol — the definitive management thread

Dr.GastroMayo Thu, May 21, 2026 at 6:36 AM 5 replies 413 viewsPage 1 of 1
Dr.GastroMayo
VIP Member
2,345
13,456
Jan 2024
Mayo Clinic, MN
May 21, 2026 at 6:36 AM#1

The nausea I get is not really nausea, it is an aversion. Food I want in the abstract becomes repellent in front of me, which no side-effect list describes.

Solved, and the fix was not the one I had assumed, so the reasoning is worth more than the answer.

What it turned out to be: Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts. Receptor-level tachyphylaxis to the delayed-emptying effect develops over weeks while the central appetite effect persists, so the same dose is materially more comfortable at week six than at week two. A slower ladder therefore reaches the same dose with less cumulative nausea, not the same nausea spread thinner.

What I am trying to establish is whether holding at a lower dose for longer actually reduces total side-effect burden or just spreads it out. Tell me what I have not thought of.

41 11mike_nyc, VendorMark, COA_Karl and 38 others
Reply Quote Save Share Report
InsuranceTom
Senior Member
1,345
7,890
Mar 2024
Connecticut
May 21, 2026 at 6:57 AM#2

Taking the question as asked, rather than the general version of it. The line between titrate-through and stop is not severity, it is trajectory and what else is present. Nausea that peaks and improves within a week is the expected pattern. Nausea that is escalating, or that comes with severe upper-abdominal pain radiating to the back, or that prevents fluids for more than a day, is a different conversation and belongs with a clinician the same day.

Last edited: May 21, 2026 at 11:57 AM
40 10lucas_SP_BR, lisa_labSD, adam_van and 37 others
Reply Quote Save Share Report
LarryQC_SD
Senior Member
2,123
9,876
Jan 2024
San Diego, CA
May 21, 2026 at 7:18 AM#3
InsuranceTom said:
The line between titrate-through and stop is not severity, it is trajectory and what else is present.

No disagreement with InsuranceTom. One condition attached. The meal advice is right and incomplete without the hydration point. People stop drinking because drinking makes them feel full, then attribute dehydration symptoms to the drug.

Last edited: May 21, 2026 at 8:18 AM
39 9TinaHashiRN, robert_kc, dan_philly and 36 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
steve_okc
Member
489
2,123
Jul 2024
Oklahoma City, OK
May 21, 2026 at 7:39 AM#4
Dr.GastroMayo said:
Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

Can confirm the pattern Dr.GastroMayo describes. The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the fat fraction of meals in the two days after dosing, and do not lie down straight after eating. Most of what people call unmanageable nausea is a meal-size and meal-composition problem interacting with a stomach that is emptying slowly.

Last edited: May 21, 2026 at 11:39 AM
38 8CanadaChris, ZaraB_AL, JakeSmashed95 and 35 others
Reply Quote Save Share Report
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
May 21, 2026 at 9:34 AM#5

Clinical perspective, offered as context rather than as advice. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

37 7GenomicsKate, Dr.ObesityMed, HealthEcon_DC and 34 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register